Author Correction: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (Nature Immunology, (2020), 21, 2, (178-185), 10.1038/s41590-019-0578-8)

Michael D. Crowther; Garry Dolton; Mateusz Legut; Marine E. Caillaud; Angharad Lloyd; Meriem Attaf; Sarah A.E. Galloway; Cristina Rius; Colin P. Farrell; Barbara Szomolay; Ann Ager; Alan L. Parker; Anna Fuller; Marco Donia; James McCluskey; Jamie Rossjohn; Inge Marie Svane; John D. Phillips; Andrew K. Sewell

ArticleOPEN ACCESS

Author Correction: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (Nature Immunology, (2020), 21, 2, (178-185), 10.1038/s41590-019-0578-8)

Nature Immunology

DOI: 10.1038/s41590-020-0640-6

3Citations

31Readers

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite

CITATION STYLE

APA

Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., … Sewell, A. K. (2020, June 1). Author Correction: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (Nature Immunology, (2020), 21, 2, (178-185), 10.1038/s41590-019-0578-8). Nature Immunology. Nature Research. https://doi.org/10.1038/s41590-020-0640-6

Author Correction: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (Nature Immunology, (2020), 21, 2, (178-185), 10.1038/s41590-019-0578-8)

Abstract

Cite

Register to see more suggestions